Congrats to anyone who got in below 65.
The 2 animal trial results were the perfect catalyst to shake the deadwood with the magnitude of the drop. Too good to pass up, I nibbled some more over my typical portfolio allocation.
No gaps in the chart now, ancillary trials done with, onward and upward.